Mary Lou Smith

发表

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

Amy M. Sitapati, W. Gradishar, R. Aft, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

A spotlight on avoidance coping to manage fear of recurrence among breast cancer survivors in an eHealth intervention

Daniel L. Hall, D. Mohr, W. Gradishar, 2022, Journal of Behavioral Medicine.

NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.

Amy M. Sitapati, W. Gradishar, R. Aft, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

In Vitro Evaluation of l-ÃŸ-D-Arabinofuranosylcytosine-ÃŸ-2'-DeoxythioguanosineCombination Chemotherapy1

E. Freireich, G. Bodey, J. Gottlieb, 2006 .

Breast Cancer, Version 3.2022

Amy M. Sitapati, W. Gradishar, R. Aft, 2022 .

Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG‐ACRIN's Symptom Outcomes and Practice Patterns study

C. Cleeland, M. Sesto, A. Tevaarwerk, 2016, Cancer.

Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates

A. Wolff, K. Wiseman, L. Wagner, 2022, BMC cancer.

Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials

L. Wagner, G. Rocque, L. Wallner, 2022, The oncologist.

Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials.

G. Kimmick, W. Dale, H. Muss, 2022, Journal of the National Cancer Institute. Monographs.

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

J. Foster, W. Woodward, L. Pusztai, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer Treatment

N. Tung, L. Wagner, G. Rocque, 2022, JCO oncology practice.

NCCN Guidelines® Insights: Breast Cancer, Version 4.2023.

W. Gradishar, R. Aft, M. Dwyer, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

Amy M. Sitapati, Amy Sitapati, Andres Forero, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Breast cancer: noninvasive and special situations.

B. Ljung, E. Winer, S. Edge, 2010, Journal of the National Comprehensive Cancer Network : JNCCN.

Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

Amy M. Sitapati, W. Gradishar, R. Aft, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

Daniel L. Koller, R. Gray, Lang Li, 2014, British Journal of Cancer.

Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology.

Amy P Abernethy, Joseph Lipscomb, C Daniel Mullins, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Guidelines Insights: Breast Cancer, Version 1.2017.

Amy M. Sitapati, W. Gradishar, Rashmi Kumar, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Breast cancer version 3.2014.

B. Ljung, C. Hudis, W. Gradishar, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Invasive breast cancer.

B. Ljung, D. Mankoff, S. Edge, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103.

Daniel L. Koller, G. Sledge, T. Foroud, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer version 2.2015: Clinical practice guidelines in oncology

Benjamin O. Anderson, Matthew Philip Goetz, Lee S. Schwartzberg, 2015 .

NCCN Guidelines Insights: Breast Cancer, Version 3.2018.

Amy M. Sitapati, B. Ljung, D. Mankoff, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Invasive breast cancer version 1.2016

C. Hudis, W. Gradishar, Rashmi Kumar, 2016 .

Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.

B. Ljung, D. Mankoff, S. Edge, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines.

B. Ljung, D. Mankoff, S. Edge, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Featured Updates to the NCCN Guidelines

Amy M. Sitapati, W. Gradishar, Rashmi Kumar, 2015 .

NCCN Guidelines Insights: Breast Cancer, Version 1.2017.

Amy M. Sitapati, W. Gradishar, Rashmi Kumar, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights Breast Cancer, Version 1.2016.

C. Hudis, W. Gradishar, Rashmi Kumar, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Breast cancer. Clinical practice guidelines in oncology.

B. Ljung, C. Hudis, W. Gradishar, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines Insights: Breast Cancer, Version 3.2018.

Amy M. Sitapati, W. Gradishar, R. Aft, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023.

E. Conant, D. Wolverton, Rashmi Kumar, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

W. Gradishar, Rashmi Kumar, H. Rugo, 2024, Journal of the National Comprehensive Cancer Network : JNCCN.

Sexual morbidity, quality of life, and patient-provider communication among ovarian cancer patients and survivors

A. Zaleta, M. Miller, R. Salani, 2021, Gynecologic Oncology.